Centre for Cancer Biomarkers CCBIO

Research groups

Across the different core programs, several areas of research and specific projects have been initiated at CCBIO, focusing on mechanisms of tumor-microenvironment interactions and tumor progress, discovery and validation of tumor biomarkers, and clinical studies.

CCBIO first principal investigators, from the start in 2013. From the left: Bjørn Tore Gjertsen, James B. Lorens, Karl H. Kalland, Anne Chr. Johannessen, Lars A. Akslen, Rolf K. Reed, the late Helga B. Salvesen, Oddbjørn Straume, Donald Gullberg.
Tove Lise Mossestad

CCBIO has 4 research teams and programs:

Team 1: Mechanisms of Tumor-Microenvironment Interactions (Preclinical Studies)

Team 2: Exploration and Validation of Cancer Biomarkers (Biomarker Validation)

Team 3: Clinical Applications and Trial Studies (Clinical Studies)

Team 4: Health Ethics, Prioritization and Economics

  • CCBIO PI Roger Strand (ethics)   PubMed publications
  • CCBIO Associate Investigator John Cairns (health economics)
  • CCBIO Associate Investigator Ole Frithjof Norheim (prioritization)

In addition, Bioinformatics is an important intersecting research area at CCBIO: